A detailed history of Huntington National Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, Huntington National Bank holds 13,899 shares of AZN stock, worth $920,808. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,899
Previous 12,877 7.94%
Holding current value
$920,808
Previous $1 Million 7.87%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.67 - $87.62 $78,356 - $89,547
1,022 Added 7.94%
13,899 $1.08 Million
Q2 2024

Aug 08, 2024

BUY
$66.81 - $80.83 $271,582 - $328,573
4,065 Added 46.13%
12,877 $1 Million
Q1 2024

May 03, 2024

BUY
$61.03 - $69.57 $48,579 - $55,377
796 Added 9.93%
8,812 $597,000
Q4 2023

Feb 07, 2024

SELL
$61.89 - $69.28 $98,776 - $110,570
-1,596 Reduced 16.6%
8,016 $539,000
Q3 2023

Nov 08, 2023

SELL
$64.85 - $71.7 $50,907 - $56,284
-785 Reduced 7.55%
9,612 $650,000
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $101,928 - $110,530
1,458 Added 16.31%
10,397 $744,000
Q1 2023

May 10, 2023

SELL
$63.15 - $71.6 $18,060 - $20,477
-286 Reduced 3.1%
8,939 $620,000
Q4 2022

Feb 09, 2023

BUY
$54.21 - $70.44 $1,951 - $2,535
36 Added 0.39%
9,225 $625,000
Q3 2022

Nov 07, 2022

BUY
$53.02 - $135.75 $20,783 - $53,214
392 Added 4.46%
9,189 $504,000
Q2 2022

Aug 09, 2022

SELL
$59.26 - $71.14 $8,770 - $10,528
-148 Reduced 1.65%
8,797 $581,000
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $100,908 - $121,554
1,811 Added 25.39%
8,945 $593,000
Q4 2021

Jan 21, 2022

BUY
$54.02 - $63.83 $160,439 - $189,575
2,970 Added 71.33%
7,134 $416,000
Q3 2021

Oct 28, 2021

BUY
$55.56 - $60.79 $33,169 - $36,291
597 Added 16.74%
4,164 $250,000
Q2 2021

Jul 30, 2021

SELL
$48.42 - $60.18 $29,971 - $37,251
-619 Reduced 14.79%
3,567 $214,000
Q1 2021

Apr 12, 2021

SELL
$47.16 - $54.44 $4,716 - $5,444
-100 Reduced 2.33%
4,186 $208,000
Q4 2020

Jan 11, 2021

SELL
$48.52 - $58.02 $79,281 - $94,804
-1,634 Reduced 27.6%
4,286 $215,000
Q3 2020

Oct 30, 2020

SELL
$53.07 - $61.1 $6,686 - $7,698
-126 Reduced 2.08%
5,920 $325,000
Q2 2020

Jul 30, 2020

SELL
$43.1 - $55.31 $4,094 - $5,254
-95 Reduced 1.55%
6,046 $320,000
Q1 2020

Apr 27, 2020

SELL
$37.79 - $51.33 $28,909 - $39,267
-765 Reduced 11.08%
6,141 $275,000
Q4 2019

Jan 17, 2020

BUY
$42.46 - $50.46 $118,123 - $140,379
2,782 Added 67.46%
6,906 $344,000
Q3 2019

Nov 01, 2019

BUY
$40.12 - $45.47 $3,891 - $4,410
97 Added 2.41%
4,124 $183,000
Q2 2019

Jul 23, 2019

BUY
$37.28 - $41.68 $10,773 - $12,045
289 Added 7.73%
4,027 $166,000
Q1 2019

Apr 09, 2019

SELL
$35.49 - $43.02 $36,874 - $44,697
-1,039 Reduced 21.75%
3,738 $151,000
Q4 2018

Jan 28, 2019

SELL
$36.86 - $41.49 $20,936 - $23,566
-568 Reduced 10.63%
4,777 $181,000
Q3 2018

Oct 18, 2018

BUY
$34.76 - $39.72 $74,108 - $84,683
2,132 Added 66.36%
5,345 $212,000
Q2 2018

Jul 19, 2018

SELL
$34.55 - $37.05 $5,908 - $6,335
-171 Reduced 5.05%
3,213 $113,000
Q1 2018

Apr 30, 2018

SELL
$32.97 - $36.63 $16,485 - $18,315
-500 Reduced 12.87%
3,384 $118,000
Q4 2017

Feb 02, 2018

SELL
$32.09 - $34.78 $19,061 - $20,659
-594 Reduced 13.26%
3,884 $135,000
Q3 2017

Oct 24, 2017

BUY
$28.96 - $34.0 $129,682 - $152,252
4,478
4,478 $152,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.